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AbsTrACT
background Although the Head Positioning in acute 
Stroke Trial (HeadPoST) showed no effect of the flat head 
position (FP; vs sitting up head position (SUP)) on functional 
outcome, we hypothesised that it could still offer benefits 
if commenced early in those with acute ischaemic stroke 
(AIS) of at least moderate severity.
Methods Subgroup analysis of HeadPoST in participants 
with National Institutes of Health Stroke Scale (NIHSS) 
scores ≥7, ≥10 and ≥14, randomised to FP or SUP 
<4.5 hours of AIS onset on functional outcomes defined by 
a shift in scores on the modified Rankin scale (mRS) and 
death/disability (mRS scores 3–6), and any cardiovascular 
serious adverse event. Logistic regression analyses were 
undertaken adjusted for study design and baseline risk 
factors.
results There was no significant differential treatment 
effect in patient subgroups defined by increasing baseline 
NIHSS scores: adjusted OR and 95% CI for ordinal shift and 
binary (3–6) mRS scores: for NIHSS ≥7 (n=867) 0.92 (0.67 
to 1.25) and 0.74 (0.52 to 1.04); NIHSS ≥ 10 (n=606) 0.80 
(0.58 to 1.10) and 0.77 (0.49 to 1.19); NIHSS ≥14 (n=378) 
0.82 (0.54 to 1.24) and 1.22 (0.69 to 2.14).
Conclusions Early FP had no significant effect in patients 
with moderate–severe AIS.
Trial registration number NCT02162017.
Small non- randomised studies1 2 indicate 
that patients with acute ischaemic stroke 
(AIS) who are positioned lying flat (FP) have 
increased mean cerebral blood flow velocity 
(CBFV) in the middle cerebral artery (MCA), 
as measured by transcranial Doppler (TCD). 
Whether this physiological association trans-
lates into improved clinical outcome has 
been hotly debated. The Head Positioning 
in Stroke Trial (HeadPoST) mechanistic 
pilot study3 confirmed an increased CBFV 
in the ipsilateral MCA (primary outcome), 
but without any benefit on 90- day functional 
outcome, which was further confirmed in the 
main HeadPoST4 study undertaken in over 
10 000 patients who were evaluated using an 
international pragmatic cluster cross- over 
design. The later study has been criticised 
for including a broad range of patients, many 
with mild deficits, who were randomised 
within a long time window from symptom 
onset, as well as for including patients with 
primary intracerebral haemorrhage.5 Herein, 
we present post- hoc analyses specifically in the 
subgroup of patients with AIS with moderate–
severe neurological impairment, defined by 
National Institutes of Health Stroke Scale 
(NIHSS) scores≥7, who commenced the head 
positioning intervention early after the onset 
of symptoms.
MeThods
HeadPoST main was an international, multi-
centre, cluster- randomised, cross- over, open- 
label trial with blinded outcome evaluation 
in 11 093 adults (age ≥18 years) with AIS or 
intracranial hemorrhage (ICH) of flat head 
position (0°) compared with sitting up (≥30°, 
SP) head positioning, applied <24 hours 
of admission at 114 hospitals in 9 countries 
during 2016–2017. The protocol is described 
in detail elsewhere, was approved by all ethics 
committees at each participating centre 
and involved informed consent obtained 
from patients or their approved surrogates.4 
This study pertains to participants with AIS 
randomised <4.5 hours with baseline high 
NIHSS scores, grouped as <7, ≥7, ≥10 and 
≥14. Clinical outcomes were a shift in scores 
on the modified Rankin scale (mRS), death 
or disability (mRS 3–6) and any serious cardi-
ovascular adverse event (SAE) including 
stroke, cardiac or other vascular events within 
90 days post randomisation. We further 
analysed the treatment effect by subgroups 
with or without large vessel occlusion (LVO) 
in each stratum of NIHSS score. The presence 
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Table 1 Baseline characteristics of patients who commenced head positioning within 4.5 hours of acute ischaemic stroke 






Age (years) 73.1 (13.3) 72.3 (13.5) 0.35
Male 230 (53.2%) 233 (53.6%) 0.92
Region, n (%) 0.08
  Australia and UK 294 (68.1) 272 (62.5)
  China and Taiwan 91 (21.1) 107 (24.6)
  India and Sri Lanka 13 (3.0) 7 (1.6)
  South America 34 (7.9) 49 (11.3)
Hypertension, n (%) 288 (67.1) 265 (60.9) 0.06
Previous stroke, n (%) 89 (20.6) 103 (23.7) 0.28
Atrial fibrillation, n (%) 95 (22.2) 94 (21.8) 0.86
Heart failure, n (%) 36 (8.5) 34 (7.9) 0.77
Diabetes mellitus, n (%) 86 (20.0) 73 (16.8) 0.23
Current smoker, n (%) 60 (14.2) 60 (14.0) 0.91
Aspirin use, n (%) 141 (32.7) 154 (35.4) 0.40
Anticoagulant use, n (%) 53 (12.3) 47 (10.9) 0.50
AIS category, n (%) 0.58
  Large vessel 133 (30.8) 134 (30.8)
  Cardioembolic 110 (25.5) 101 (23.2)
  Lacunar 59 (13.7) 52 (12.0)
  Other 130 (30.1) 148 (34.0)
NIHSS at admission 13.0 (9.0 to 18.0) 12.0 (9.0 to 18.0) 0.34
mRS, n (%) 0.73
  0 (no symptoms) 251 (58.5) 246 (56.8)
  1 (no significant disability) 73 (17.0) 73 (16.9)
  2 (slight disability) 40 (9.3) 47 (10.9)
  3 (moderate disability) 41 (9.6) 42 (9.7)
  4 (moderate/severe disability) 22 (5.1) 19 (4.4)
  5 (severe disability) 2 (0.5) 6 (1.4)
Data are n (%), mean (SD) and median (IQR).
AIS, acute ischaemic stroke; mRS, modified Rankin scale.
of LVO was defined as an occlusion of MCA segments M1 
or M2, terminal internal carotid artery, A1 segment of the 
anterior cerebral artery, P1 segment of the posterior cere-
bral artery or vertebral/basilar arteries on CT/MR angi-
ography, digital subtraction, or by TCD.
Baseline characteristics and relevant hospital care were 
analysed with the χ2 test for categorical variables, t- test 
for normally distributed and Wilcoxon rank sum test for 
skewed distribution, as appropriate. Treatment effects 
were analysed by ordinal logistic regression, with a hier-
archical mixed model and adjustment for study design 
(fixed intervention effect, fixed period effect, random 
cluster effect and effect of the interaction between 
random cluster and period). Subsequent models were 
adjusted for baseline confounders of age, sex, region, 
premorbid functional grade on the mRS, history of heart 
disease, diabetes mellitus, or stroke, and NIHSS score, 
with a forward approach. Results are presented as OR and 
95% CIs. A standard two- sided level p<0.05 was consid-
ered significant. All analyses were performed with SAS 
software V.9.4 (SAS Institute).
resulTs
Online supplementary figure 1 shows the flow of patients 
flow according to NIHSS score subgroups. Table 1 shows 
the baseline demographic and clinical characteristics 
of 867 patients with NIHSS ≥7, which were comparable 
between randomised groups. Similarly, there were no 
significant baseline differences in patient groups of 
NIHSS <7 (n=950), ≥10 (n=606) or ≥14 (n=378; online 
supplemental appendix, tables S1–3, respectively). At 
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Table 2 90- day outcomes by baseline neurological severity
Outcome* Lying flat versus sitting up OR (95% CI) P value aOR (95% CI) P value
NIHSS <7
  Ordinal mRS 1.07 (0.83 to 1.37) 0.62 1.03 (0.80 to 1.33) 0.73
  Binary mRS 3–6 26.6% versus 26.2% 1.02 (0.72 to 1.45) 0.89 0.93 (0.63 to 1.37) 0.70
  Death 3.9% versus 3.2% 1.31 (0.65 to 2.66) 0.46 Did not converge†
  Cardiovascular SAEs* 7.3% versus 7.2% 1.03 (0.62 to 1.72) 0.90 1.05 (0.62 to 1.78) 0.85
NIHSS≥7
  Ordinal mRS 0.94 (0.71 to 1.26) 0.69 0.92 (0.67 to 1.25)‡ 0.59
  Binary mRS 3–6 58.7% versus 62.2% 0.86 (0.67 to 1.15) 0.31 0.74 (0.52 to 1.04) 0.08
  Death 13.6% versus 15.4% 0.91 (0.59 to 1.41) 0.67 0.80 (0.51 to 1.27) 0.34
  Cardiovascular SAEs* 16.0% versus 12.2% 1.31 (0.87 to 1.99) 0.20 1.21 (0.79 to 1.86) 0.37
NIHSS ≥10
  Ordinal mRS 0.87 (0.64 to 1.19) 0.38 0.80 (0.58 to 1.10) 0.16
  Binary mRS 3–6 68.1% versus 69.6% 0.89 (0.61 to 1.30) 0.55 0.77 (0.49 to 1.19) 0.24
  Death 17.2% versus 20.5% 0.85 (0.52 to 1.38) 0.50 0.76 (0.46 to 1.24) 0.27
  Cardiovascular SAEs* 17.9% versus 15.4% 1.16 (0.73 to 1.83) 0.54 1.06 (0.66 to 1.70) 0.81
NIHSS ≥14
  Ordinal mRS 0.83 (0.56 to 1.27) 0.36 0.82 (0.54 to 1.24) 0.34
  Binary mRS 3–6 77.3% versus 75.0% 1.13 (0.65 to 1.98) 0.66 1.05 (0.54 to 2.01) 0.89
  Death 22.8% versus 27.8% 0.70 (0.42 to 1.19) 0.19 0.72 (0.40 to 1.30) 0.28
  Cardiovascular SAEs* 23.5% versus 18.1% 1.29 (0.75 to 2.21) 0.36 1.30 (0.73 to 2.31) 0.38
Adjusted OR (aOR) obtained for further adjusted age, sex, region groups, premorbid grade (0–1 vs 2–5) according to modified Rankin scale 
(mRS) assessed at baseline, comorbidity of heart disease, stroke or diabetes mellitus and National Institutes of Health Stroke Scale (NIHSS) 
at baseline as continuous variable.
*Cardiovascular serious adverse events (SAEs) include cerebrovascular events, cardiac events or other vascular events.
†Hierarchical model cannot be converge due to very few cases of death in this subgroup.
‡Hierarchical model only adjusted study design, age, sex, region groups, premorbid grade (0–1 vs 2–5) according to mRS assessed at 
baseline and comorbidity of heart disease, stroke or diabetes mellitus.
90 days post randomisation, there was no significant differ-
ence in functional recovery by ordinal mRS (adjusted OR 
(aOR) 0.92, 95% CI 0.67 to 1.25), binary mRS scores 3–6 
(aOR 0.74, 95% CI 0.52 to 1.04) or any cardiovascular 
SAE (aOR 1.21, 95% CI 0.79 to 1.86, table 2) in NIHSS ≥7 
group. Likewise, there were no significant differences in 
the treatment effects on these outcomes in patients with 
NIHSS scores <7, ≥10 and ≥14 (table 2; online supple-
mentary figure 2). The probability of a good outcome 
was significantly greater in the patients with LVO and an 
NIHSS <7 (p=0.005 for interaction).
disCussion
In these post- hoc analyses of participants in the Head-
PoST study with more severe neurological deficit, there 
was no differential effect of randomised head positioning 
commenced early after onset of symptoms on functional 
outcomes or cardiovascular SAE. These patients had a 
high likelihood of a large ischaemic penumbra, based 
on an early time window after symptom onset6 and high 
probability of underlying LVO by virtue of an initial 
NIHSS score ≥7.7 Although we cannot exclude the possi-
bility of missing a more modest effect from low statistical 
power in subgroups or of poor fidelity of the interven-
tion, these results provide further confirmation that any 
change in MCA CBFV from the FP does not appear to 
translate into improved clinical outcomes as compared 
with SP in patients with severe AIS.
We have previously shown that in the FP group, 14% 
more patients had an increase of CBFV of ≥8 cm/s over 
24 hours in the ipsilateral MCA when compared with 
SP after AIS.3 While this increase in CBFV could influ-
ence NIHSS score improvement after AIS,1 this may 
not necessarily influence overall recovery at 90 days,3 4 
as such change in CBFV represents only an increase of 
13%–17% of the flow velocity of a normal artery.8 It is 
unknown if such a modest increase in flow velocity is 
able to maintain viable penumbra over a longer period 
of time, even up to 24 hours.9 TCD evaluations of 
acute MCA occlusions in AIS are usually scored on the 
Thrombolysis in Brain Ischaemia (TIBI) scale (from 0 
being occluded to 5 representing normal flow velocity), 
and have shown that a change in ultrasonographic flow 
patterns from a TIBI signal of 0–3 to 4–5 is associated 
with good functional outcome. These changes in TIBI 
scores represent a minimum threefold increase in flow 
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velocity of an affected artery (change from TIBI 3–5).10 
Thus, it is unlikely that an increase of 13% in flow 
velocity in 14% of patients, who were assigned to FP, 
could have had a significant effect on overall recovery. 
Moreover, no study has shown that changes in CBFV 
equate to improvements in the ischaemic penumbra.9 
Even within patients with AIS with the highest NIHSS 
scores (≥10 and ≥14),7 9 11 we could not detect a treat-
ment effect. Nevertheless, we did find a significant 
interaction between LVO and low NIHSS, favouring 
FP, which could indicate that these patients have good 
collaterals from mild clinical manifestations. The find-
ings could also be due to chance in only 42 patients 
randomised to FP.
One explanation for our neutral results in patients 
with high NIHSS scores is that FP has no effect if there 
is no collateral blood flow, even in the very early stages 
of AIS.6 It is possible that FP could still have some effect 
in highly selected patients, such as those with LVO and 
very competent collaterals, or those with incomplete 
reperfusion from lysis or mechanical thrombectomy 
therapies, but this will be challenging to prove in a 
randomised trial.
An important caveat is that while our study included 
a very large number of randomised patients who had 
severe strokes, only a small proportion had imaging 
confirmation of the location and extent of vessel occlu-
sion. Moreover, these are post- hoc analyses of subgroups 
and thus prone to bias and random effects.
In summary, the use of FP of patients early after the 
onset of moderate–severe AIS was not associated with 
functional recovery, but could be effective in patients 
with low NIHSS and LVO.
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